Armata Pharmaceuticals (ARMP) Cash from Operations Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.10% |
| Dec 31, 2025 | -1.15% |
| Sep 30, 2025 | -2.07% |
| Jun 30, 2025 | -13.34% |
| Mar 31, 2025 | -12.36% |
| Dec 31, 2024 | -23.77% |
| Sep 30, 2024 | -14.18% |
| Jun 30, 2024 | -11.80% |
| Mar 31, 2024 | -33.90% |
| Dec 31, 2023 | -20.47% |
| Sep 30, 2023 | -36.83% |
| Jun 30, 2023 | -45.09% |
| Mar 31, 2023 | -37.80% |
| Dec 31, 2022 | -34.65% |
| Sep 30, 2022 | -77.11% |
| Jun 30, 2022 | -22.69% |
| Mar 31, 2022 | -1.28% |
| Dec 31, 2021 | -41.83% |
| Sep 30, 2021 | -9.66% |
| Jun 30, 2021 | -9.43% |
| Mar 31, 2021 | -12.16% |
| Dec 31, 2020 | -22.15% |
| Sep 30, 2020 | -9.22% |
| Jun 30, 2020 | -7.69% |
| Mar 31, 2020 | -12.92% |
| Dec 31, 2019 | 3.13% |
| Sep 30, 2019 | -11.70% |
| Jun 30, 2019 | -13.79% |
| Mar 31, 2019 | 7.80% |
| Dec 31, 2018 | -17.74% |
| Sep 30, 2018 | 4.13% |
| Jun 30, 2018 | -8.17% |
| Mar 31, 2018 | -25.87% |